Company Filing History:
Years Active: 2016-2019
Title: Mark Edward Tometsko: Innovator in BCMA Antigen Binding Proteins
Introduction
Mark Edward Tometsko is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of BCMA (B-Cell Maturation Antigen) antigen binding proteins. With a total of 3 patents to his name, Tometsko's work is paving the way for advancements in medical treatments.
Latest Patents
Tometsko's latest patents focus on BCMA antigen binding proteins. These inventions include antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. Additionally, his work encompasses BCMA antibody drug conjugates and their various uses.
Career Highlights
Mark Edward Tometsko is currently employed at Amgen Inc., a leading biotechnology company. His role at Amgen allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Some of Tometsko's notable coworkers include Richard Jeffrey Armitage and Michelle Blake. Their combined expertise enhances the innovative environment at Amgen Inc.
Conclusion
Mark Edward Tometsko is a prominent figure in the biotechnology sector, with a focus on BCMA antigen binding proteins. His contributions are vital for the advancement of medical treatments and therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.